Evidence map›Paper›PMID 38626061›Full record

ArticlePloS one2024

Association between dyslipidemia and the risk of incident chronic kidney disease affected by genetic susceptibility: Polygenic risk score analysis.

Boram Weon, Yunjeong Jang, Jinyeon Jo, Wencheng Jin, Seounguk Ha, Ara Ko, Yun Kyu Oh, Chun Soo Lim, Jung Pyo Lee, Sungho Won and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Fibrates : Do They Still Have a Role in Therapy in 2025?Current atherosclerosis reports · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Boram WeonDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Yunjeong JangRexsoft Corporation, Seoul, Republic of Korea.
Jinyeon JoDepartment of Public Health Sciences, Institute of Health & Environment, School of Public Health, Seoul National University, Seoul, Republic of Korea.ORCID 0000-0002-4192-1725
Wencheng JinDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Seounguk HaKorea Medical Institute, Seoul, Republic of Korea.
Ara KoDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Yun Kyu OhDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Chun Soo LimDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.ORCID 0000-0001-9123-6542
Jung Pyo LeeDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Sungho WonRexsoft Corporation, Seoul, Republic of Korea.ORCID 0000-0001-5751-5089
Jeonghwan LeeDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.ORCID 0000-0003-3199-635X
Seoul National University · KRSeoul National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe effect of dyslipidemia on kidney disease outcomes has been inconclusive, and it requires further clarification. Therefore, we aimed to investigate the effects of genetic factors on the association between dyslipidemia and the risk of chronic kidney disease (CKD) using polygenic risk score (PRS).

methodsWe analyzed data from 373,523 participants from the UK Biobank aged 40-69 years with no history of CKD. Baseline data included plasma levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride, as well as genome-wide genotype data for PRS. Our primary outcome, incident CKD, was defined as a composite of estimated glomerular filtration rate < 60 ml/min/1.73 m2 and CKD diagnosis according to International Classification of Disease-10 codes. The effects of the association between lipid levels and PRS on incident CKD were assessed using the Cox proportional hazards model. To investigate the effect of this association, we introduced multiplicative interaction terms into a multivariate analysis model and performed subgroup analysis stratified by PRS tertiles.

resultsIn total, 4,424 participants developed CKD. In the multivariable analysis, PRS was significantly predictive of the risk of incident CKD as both a continuous variable and a categorized variable. In addition, lower total cholesterol, LDL-C, HDL-C, and higher triglyceride levels were significantly associated with the risk of incident CKD. There were interactions between triglycerides and intermediate and high PRS, and the interactions were inversely associated with the risk of incident CKD.

conclusionsThis study showed that PRS presented significant predictive power for incident CKD and individuals in the low-PRS group had a higher risk of triglyceride-related incident CKD.

Indexed as

DyslipidemiasRenal Insufficiency, ChronicCholesterol, HDLGenetic Predisposition to DiseaseGenetic Risk ScoreHumansRisk FactorsTriglyceridesCholesterol, HDLTriglycerides

Identifiers

PMID38626061
PMCPMC11020804
OpenAlexW4394841328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.